Remed Co.,Ltd. (KOSDAQ:302550)
2,890.00
-70.00 (-2.36%)
At close: May 29, 2026
Remed Revenue
Remed had revenue of 7.18B KRW in the quarter ending March 31, 2026, with 11.37% growth. This brings the company's revenue in the last twelve months to 25.24B, down -5.41% year-over-year. In the year 2025, Remed had annual revenue of 24.50B, down -4.11%.
Revenue (ttm)
25.24B
Revenue Growth
-5.41%
P/S Ratio
3.54
Revenue / Employee
274.32M
Employees
92
Market Cap
89.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.50B | -1.05B | -4.11% |
| Dec 31, 2024 | 25.55B | 7.02B | 37.86% |
| Dec 31, 2023 | 18.54B | -2.83B | -13.23% |
| Dec 31, 2022 | 21.36B | 1.17B | 5.79% |
| Dec 31, 2021 | 20.20B | 3.56B | 21.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 108.04B |
| DRGEM | 106.74B |
| JPI Healthcare | 47.97B |
| L&K Biomed | 39.53B |
| Hironic | 34.19B |
| SELVAS Healthcare | 30.19B |
| Dynamic solution | 16.05B |
| MEKICS CO., | 12.26B |